Quick Answer
Vaxcyte, Inc. reported Shares Outstanding of 131.06 million shares for fiscal year 2025.
Vaxcyte, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 131.06M | +4.9% |
| 2024 | 124.89M | +31.0% |
| 2023 | 95.36M | +20.0% |
| 2022 | 79.47M | +49.9% |
| 2021 | 53.03M | +3.8% |
| 2020 | 51.07M | +1157.9% |
| 2019 | 4.06M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 130.03M | +4.5% | +0.2% |
| June 30, 2025 | 129.82M | +17.4% | +0.7% |
| March 31, 2025 | 128.94M | +18.6% | +3.2% |
| December 31, 2024 | 124.89M | +31.0% | +0.4% |
| September 30, 2024 | 124.43M | +30.8% | +12.5% |
| June 30, 2024 | 110.58M | +17.9% | +1.7% |
| March 31, 2024 | 108.76M | +34.9% | +14.0% |
| December 31, 2023 | 95.36M | +20.0% | +0.3% |
- Vaxcyte, Inc. showed an increase of +4.9% in Shares Outstanding compared to the prior fiscal year.
- Over the 2019–2025 period, Vaxcyte, Inc.’s shares outstanding has grown by 3128.1% (from 4.06 million shares to 131.06 million shares).
- The most recent figure is from Vaxcyte, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: